AIP files Rule 144 to sell 11,841 shares on NASDAQ
Rhea-AI Filing Summary
Arteris, Inc. insider notice reports a proposed sale under Rule 144 of 11,841 common shares with an aggregate market value of
Positive
- 11,841 shares identified for sale were acquired on 01/28/2021 via previously exercised stock options
- Proposed sale lists a named institutional broker: Morgan Stanley Smith Barney LLC
- Filer included prior sale detail: 6,909 shares sold on
08/05/2025 for$97,699.48 , showing transaction transparency
Negative
- Proposed insider sale of 11,841 shares with market value
$130,014.18 may be viewed unfavorably by some investors - Recent sale activity ( 6,909 shares on
08/05/2025 ) indicates ongoing insider liquidity events
Insights
Small scheduled insider sale from exercised options; shows planned liquidity, not new issuance.
The filing documents a proposed Rule 144 sale of 11,841 common shares acquired via previously exercised stock options on
Key dependencies include timing of execution and whether the seller relies on a 10b5-1 plan; the form contains the usual attestation about material nonpublic information. Watch for an actual Form 4 or trade report shortly after
Filing follows Rule 144 mechanics and includes prior 10b5-1 sales disclosure.
The notice lists acquisition details, purchase consideration (cash), and prior sales including a
Compliance attention should focus on any accompanying 10b5-1 plan dates and subsequent public filings showing actual sales; those items will clarify whether the transactions were preplanned or discretionary within the near term.